Interactive Research Atlas

Explore the science of peptides. with NuMe

Explore peptides by biological system, research area and mechanism. Select one or more areas of the body to discover related research.

Peptide Research
22 peptides found
DSIP
Neuropeptide
Experimental research
A peptide originally isolated in association with sleep-related research and subsequently investigated for several neurophysiological effects.
Brain & CNS Sleep & Circadian
Not an approved therapeutic drug
Explore research
Dulaglutide
GLP-1 receptor agonist
Established clinical compound
A long-acting GLP-1 receptor agonist developed for glucose regulation in type 2 diabetes.
Brain & CNS Cardiovascular Gastrointestinal Pancreas & Glucose Metabolic Endocrine & Hormonal
Approved prescription drug for specific indications
Explore research
Epitalon
Synthetic tetrapeptide
Experimental research
A synthetic tetrapeptide investigated primarily in aging, cellular regulation and telomere-related experimental research.
Brain & CNS Sleep & Circadian Endocrine & Hormonal Cellular & Mitochondrial
Not an approved therapeutic drug
Explore research
Exenatide
GLP-1 receptor agonist
Established clinical compound
A synthetic version of exendin-4 that activates the GLP-1 receptor and has been used clinically in type 2 diabetes.
Brain & CNS Gastrointestinal Pancreas & Glucose Metabolic Endocrine & Hormonal
Approved prescription drug for specific indications
Explore research
GHRP-2
Growth hormone secretagogue
Clinical and experimental research
A synthetic peptide that acts as a growth hormone secretagogue through the ghrelin receptor.
Brain & CNS Metabolic Muscle Endocrine & Hormonal
Regulatory status varies by jurisdiction and intended use
Explore research
GHRP-6
Growth hormone secretagogue
Experimental research
A synthetic growth hormone secretagogue that activates the ghrelin receptor and has been widely used in endocrine research.
Brain & CNS Gastrointestinal Metabolic Muscle Endocrine & Hormonal
Not generally approved as a therapeutic drug
Explore research
GLP-1
Endogenous incretin peptide hormone
Extensively studied endogenous hormone
An endogenous incretin hormone produced primarily in the intestine that influences insulin secretion, glucagon signaling, gastric emptying and appetite-related pathways.
Brain & CNS Cardiovascular Gastrointestinal Liver Pancreas & Glucose Metabolic Adipose Tissue Endocrine & Hormonal
Endogenous biological molecule; synthetic receptor agonists are regulated separately
Explore research
Gonadorelin
GnRH peptide hormone
Established clinical and research compound
A synthetic form of endogenous gonadotropin-releasing hormone that stimulates pituitary release of LH and FSH.
Brain & CNS Reproductive Endocrine & Hormonal
Has had approved medical uses in some jurisdictions
Explore research
Hexarelin
Growth hormone secretagogue
Investigational
A synthetic hexapeptide growth hormone secretagogue that acts primarily through the ghrelin receptor.
Brain & CNS Cardiovascular Metabolic Muscle Endocrine & Hormonal
Not generally approved as a therapeutic drug
Explore research
Ipamorelin
Growth hormone secretagogue
Investigational
A synthetic pentapeptide and selective ghrelin-receptor agonist investigated for its ability to stimulate growth hormone release.
Brain & CNS Metabolic Muscle Endocrine & Hormonal
Not an approved therapeutic drug
Explore research
Kisspeptin-10
Neuropeptide
Clinical and experimental research
A biologically active fragment of kisspeptin involved in regulation of the hypothalamic-pituitary-gonadal axis.
Brain & CNS Reproductive Endocrine & Hormonal
Investigational for many proposed therapeutic applications
Explore research
Liraglutide
GLP-1 receptor agonist
Established clinical compound
A long-acting GLP-1 receptor agonist used clinically for specific metabolic and weight-management indications.
Brain & CNS Cardiovascular Gastrointestinal Pancreas & Glucose Metabolic Adipose Tissue Endocrine & Hormonal
Approved prescription drug for specific indications in multiple jurisdictions
Explore research
Lixisenatide
GLP-1 receptor agonist
Established clinical compound
A peptide GLP-1 receptor agonist used clinically for treatment of type 2 diabetes in some jurisdictions.
Brain & CNS Gastrointestinal Pancreas & Glucose Metabolic Endocrine & Hormonal
Approved prescription drug in certain jurisdictions
Explore research
NAD+
Cellular redox coenzyme
Extensively studied endogenous molecule
An essential cellular coenzyme involved in redox reactions, energy metabolism, DNA repair and numerous signaling pathways.
Brain & CNS Liver Metabolic Muscle Cellular & Mitochondrial
Regulatory status depends on formulation, route and intended use
Explore research
Oxytocin
Peptide hormone
Established clinical and biomedical research
An endogenous peptide hormone involved in uterine contraction, lactation and multiple central nervous system signaling pathways.
Brain & CNS Reproductive Endocrine & Hormonal
Approved prescription drug for specific medical indications
Explore research
PT-141
Melanocortin receptor agonist peptide
Clinically studied
A synthetic cyclic peptide and melanocortin receptor agonist developed from research involving alpha-MSH analogs.
Brain & CNS Reproductive
Bremelanotide is an approved prescription drug for a specific indication in the United States
Explore research
Retatrutide
Triple GIP / GLP-1 / glucagon receptor agonist
Clinical-stage investigational compound
An investigational peptide-based triple receptor agonist targeting GIP, GLP-1 and glucagon receptors, studied primarily in metabolic and obesity-related clinical research.
Brain & CNS Gastrointestinal Liver Pancreas & Glucose Metabolic Adipose Tissue Endocrine & Hormonal
Investigational; regulatory status depends on jurisdiction and indication
Explore research
Selank
Synthetic regulatory peptide
Experimental and region-specific clinical research
A synthetic peptide derived from the immunomodulatory peptide tuftsin and investigated for neurological and behavioral effects.
Brain & CNS
Regulatory status varies by jurisdiction
Explore research
Semaglutide
GLP-1 receptor agonist
Established clinical compound
A long-acting GLP-1 receptor agonist used clinically for specific metabolic indications and extensively studied in glucose regulation and body-weight management.
Brain & CNS Cardiovascular Gastrointestinal Liver Pancreas & Glucose Metabolic Adipose Tissue Endocrine & Hormonal
Approved prescription drug for specific indications in multiple jurisdictions
Explore research
Semax
Synthetic neuroactive peptide
Experimental and region-specific clinical use
A synthetic peptide derived from an ACTH fragment and investigated for neurobiological and cognitive effects.
Brain & CNS
Regulatory status varies by jurisdiction
Explore research
Sermorelin
Growth hormone-releasing hormone analog
Clinical and endocrine research
A synthetic peptide corresponding to the biologically active N-terminal portion of human growth hormone-releasing hormone.
Brain & CNS Metabolic Muscle Endocrine & Hormonal
Regulatory and product availability status varies by jurisdiction
Explore research
Tirzepatide
Dual GIP / GLP-1 receptor agonist
Established clinical compound
A peptide-based dual agonist targeting GIP and GLP-1 receptors, developed for metabolic disease and weight-management indications.
Brain & CNS Cardiovascular Gastrointestinal Liver Pancreas & Glucose Metabolic Adipose Tissue Endocrine & Hormonal
Approved prescription drug for specific indications in multiple jurisdictions
Explore research
Research information only. NuMe presents scientific and educational information about compounds appearing in published research. Inclusion in this database does not indicate that a compound is approved, safe, effective or appropriate for human use. Evidence levels vary substantially between compounds.